Assessment and communication by the food and Drug Administration (FDA) of hepatosplenic T-cell lymphoma (HSTCL) risk in children and young adults with Inflammatory Bowel Disease (IBD) treated with tumor Necrosis Factor (TNF) antagonists and thiopurines: P-157

Saved in:
Bibliographic Details
Published in:Inflammatory bowel diseases 2011-12, Vol.17, p.S60
Main Authors: Korvick, Joyce, Corken-Mackey, Ann
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1078-0998
DOI:10.1097/00054725-201112002-00191